Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Filament Health Stock News

FLHLFOTCQB

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

Filament Health (FLHLF) Forecast

News

Earnings Filament Health (FLHLF) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest Filament Health Stock News | OTC:FLHLF | Benzinga

Get the latest news on Filament Health stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Filament Health performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Wednesday, April 17, 2024

Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More
Lara Goldstein - Apr 17, 2024, 9:13AM

Saturday, March 30, 2024

Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More
Lara Goldstein - Mar 30, 2024, 8:57AM

Saturday, March 02, 2024

Psychedelics Headlines: Predicting Readiness, Correcting The Hype, Good And Bad Drugs, Training Programs And More
Lara Goldstein - Mar 1, 2024, 7:27PM

Thursday, February 15, 2024

Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More
Lara Goldstein - Feb 15, 2024, 10:55AM

Tuesday, January 30, 2024

'Rainforests Are Nature's Medicine Cabinets': Biotech Co. Performs Fresh Research On Traditional Plants For Modern Mental Health Challenges
Lara Goldstein - Jan 30, 2024, 1:52PM

Friday, January 26, 2024

Psychedelics Headlines: Anti-inflammatory Effects, Global Drug Survey, 'Synthetic Surprise,' UK's Harm Reduction Hub And More
Lara Goldstein - Jan 26, 2024, 12:33PM

Wednesday, December 27, 2023

Psyched: Biden Approves Psychedelics Trials, RFK, Australia's First Legal Dedicated Clinic & More
Lara Goldstein - Dec 27, 2023, 10:09AM

Tuesday, September 26, 2023

Psyched: Steve Cohen Goes Big On Cybin, Fed Intervention On Psilocybin, Ketamine Insurance And More
Lara Goldstein - Sep 26, 2023, 9:28AM

Thursday, September 21, 2023

Peru's Coca Leaf Will Be Used For Research Toward Treating ADHD, Learn The Details
Lara Goldstein - Sep 21, 2023, 4:46PM
Filament Health and Jaguar Health's Joint Ven...
Benzinga Newsdesk - Sep 21, 2023, 7:33AM

Thursday, August 24, 2023

Psilocybin Therapy Trials: Gambling Addiction Study, Opioid Pain & Alcohol Addiction Trials
Lara Goldstein - Aug 23, 2023, 8:09PM

Monday, August 21, 2023

Psyched: Fed Study On Psychedelics, Janet Yellen's Magic Mushrooms, Financing Deals & Quarterly Reports
Lara Goldstein - Aug 21, 2023, 10:55AM

Tuesday, August 15, 2023

Filament Health Shares Q1 2023 Financials, Material Uncertainties Upon Securing Additional Financing
Lara Goldstein - Aug 15, 2023, 6:21PM

Monday, July 24, 2023

Psyched: Germany Ships LSD Prodrugs Via DHL, Minneapolis Decriminalizes, Wiz Khalifa's Magic Pitch & More
Lara Goldstein - Jul 24, 2023, 5:14PM

Wednesday, July 19, 2023

Filament Health Uplisting To NASDAQ In A $210M SPAC Deal
Lara Goldstein - Jul 19, 2023, 5:41PM

Tuesday, July 11, 2023

Psyched: Australia's Innovative Program, Congressional Amendments, Therapy Reimbursement And More
Lara Goldstein - Jul 11, 2023, 11:25AM

Friday, July 07, 2023

Filament Supplies Botanical Psilocybin To Canadian Researchers, Inks Global Licensing Deal
Lara Goldstein - Jul 7, 2023, 3:51PM

Wednesday, May 31, 2023

UCSF Clinical Trial Shows Promising Results For Naturally-Sourced Psilocybin And Psilocin
Lara Goldstein - May 30, 2023, 8:23PM

Tuesday, May 23, 2023

Psyched: New Psilocybin Forms, LSD Anxiety Study, UK's Parliamentary Debate And More
Lara Goldstein - May 23, 2023, 7:56PM

Wednesday, May 17, 2023

African Iboga Root Heads To Canadian Company Developing Natural Drugs To Help Treat Addictions
Lara Goldstein - May 17, 2023, 6:26PM

Monday, May 15, 2023

Psyched: $20M Research Fund, LSD Microdosing For Cancer, MEAI Enters Clinical Stage, Reform Update & More
Lara Goldstein - May 15, 2023, 5:30PM
Filament Health's Q1 2023 Financial Results, Material Uncertainty On The Horizon
Lara Goldstein - May 15, 2023, 2:15PM

Monday, April 17, 2023

Psyched: Clinical-Grade MDMA, LSD For Depression, Partnerships For Delivering Psychedelic Therapies & More
Lara Goldstein - Apr 17, 2023, 4:14PM

Tuesday, April 11, 2023

Revolutionizing Psychedelics: 2 Industry Leaders Collaborate To Offer Clinical-Grade MDMA Capsules
Lara Goldstein - Apr 11, 2023, 3:10PM

Monday, April 03, 2023

Filament Health: 2022 Financials And Operational Highlights From Creator Of The Ayahuasca Pill
Lara Goldstein - Apr 3, 2023, 1:44PM

Tuesday, March 21, 2023

Psychedelic Research Expands In Australia With Palliative Care Partnership & New MDMA Analog Portfolio
Lara Goldstein - Mar 21, 2023, 3:52PM

Monday, March 20, 2023

Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More
Lara Goldstein - Mar 20, 2023, 5:11PM

Wednesday, March 15, 2023

Psychedelic Trials Update: Treating Meth Addiction, Fibromyalgia & General Anxiety Disorder
Lara Goldstein - Mar 15, 2023, 4:54PM

Tuesday, February 28, 2023

Psyched: Hawaii And Minnesota's Bills, Studying 2C-B Vs. Psilocybin, Filament CEO, Plus Brock Pierce And Jeremy Gardner Discuss The Industry's Future And More
Lara Goldstein - Feb 27, 2023, 7:28PM

Tuesday, February 21, 2023

[Video] Revolutionizing Mental Health: Filament Health CEO Discusses The Future Of Psychedelic Medicine
Benzinga Cannabis - Feb 21, 2023, 5:48PM
Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More
Lara Goldstein - Feb 21, 2023, 5:19PM

Tuesday, February 14, 2023

Supply Partnerships: Filament's Psilocybin Trial In Canada, PharmAla's MDMA Program In Australia
Lara Goldstein - Feb 14, 2023, 3:13PM

Thursday, January 26, 2023

EXCLUSIVE: Defining 'Natural' Psychedelics, State Regulations & Ayahuasca's Benefits
Lara Goldstein - Jan 26, 2023, 10:40AM

Wednesday, January 25, 2023

Psyched: States With Psychedelics Legalization Bills, Next-Gen Molecule For Addiction Treatment And More
Lara Goldstein - Jan 25, 2023, 12:02PM

Friday, January 20, 2023

Psychiatry And Business Collaborate: European Psychedelics Trial Tackles Alcohol Addiction
Lara Goldstein - Jan 20, 2023, 6:37PM

Tuesday, January 10, 2023

6 Psychedelics Companies Take Action: Here Are The Latest, Major Announcements
Lara Goldstein - Jan 10, 2023, 3:53PM

Tuesday, December 20, 2022

Psyched: First Ayahuasca Pill Created, Psychedelics Legalization Predicted, UK's Research Support And More
Lara Goldstein - Dec 19, 2022, 8:23PM

Friday, December 16, 2022

EXCLUSIVE: The Psychedelics Debate Is 'Raging' As Filament Debuts Ayahuasca Pill
Lara Goldstein - Dec 16, 2022, 10:15AM

Thursday, December 15, 2022

Psychedelics Company Filament Signs Licensing Deal With Psyence In US, UK And EU
Lara Goldstein - Dec 15, 2022, 1:38PM
EXCLUSIVE: Ayahuasca Pill Is Officially Here, Filament CEO Discusses Future Plans
Lara Goldstein - Dec 15, 2022, 12:48PM

Tuesday, December 06, 2022

Psyched: Fed Guidelines And Research Production Quotas, Protests In Canada, Cal's Decrim Project
Lara Goldstein - Dec 6, 2022, 2:20PM

Thursday, December 01, 2022

Natural Psychedelics Extraction & Standardization Obtains Two New US Patents
Lara Goldstein - Dec 1, 2022, 8:14AM

Tuesday, November 15, 2022

Psyched: Colorado Legalizes Psychedelics, NYC Treats Alcoholism With Ketamine, $30M Series A For Startup
Lara Goldstein - Nov 15, 2022, 11:46AM

Friday, November 11, 2022

Filament Health Shares Q3 2022 Results, On Road To Becoming Industry's Natural Psilocybin Supplier
Lara Goldstein - Nov 11, 2022, 2:45PM

Monday, November 07, 2022

Psyched: Brock Pierce Joins Psychedelic VC, Colorado's Psychedelics Legalization, Zappy Zapolin's Open Letter & More
Lara Goldstein - Nov 7, 2022, 5:40PM

Friday, November 04, 2022

EXCLUSIVE: Crypto Billionaire Brock Pierce Joins Psychedelic Venture Fund, Says 'Potential Reward Is Immeasurable'
Javier Hasse - Nov 4, 2022, 9:29AM

Thursday, July 28, 2022

Canada-Based Project Solace Aims To Provide Access And Data On Medical Psilocybin
Lara Goldstein - Jul 28, 2022, 10:04AM

Friday, July 08, 2022

Filament Begins First Ever FDA-Approved Clinical Trial On Naturally-Derived Psychedelic Drugs
Lara Goldstein - Jul 8, 2022, 1:09PM

Thursday, June 16, 2022

Canadian Special Access Program Further Authorizes Novel Psychedelic Drugs For Emergency Treatments
Lara Goldstein - Jun 16, 2022, 3:20PM

Wednesday, June 15, 2022

Psyched: Elon Musk Tweets About Psychedelics, Numinus Acquires Novamind, Colorado Gov. Signs MDMA Legalization Bill
Natan Ponieman - Jun 15, 2022, 12:32PM

Popular Channels

PreMarket Playbook
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved